Status:
COMPLETED
Impact of SARS-CoV-2 (COVID-19) Infection, Treated in Ambulatory Care, on Long-term Quality of Life in a Parisian Military Population
Lead Sponsor:
Direction Centrale du Service de Santé des Armées
Conditions:
SARS-CoV2 Infection
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
In April 2020, a meta-analysis on the long-term sequelae of respiratory syndromes related to seasonal coronaviruses (SARS and MERS) showed a significant alteration in quality of life, with in particul...
Eligibility Criteria
Inclusion
- Military personnel
- COVID+: diagnosed with COVID-19 and managed in ambulatory care since March 14th, 2020
- COVID-: not having been infected with SARS-CoV-2
Exclusion
- Hospitalized for COVID-19
- Having received a treatment against COVID-19 (other than paracetamol)
Key Trial Info
Start Date :
July 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 4 2022
Estimated Enrollment :
173 Patients enrolled
Trial Details
Trial ID
NCT04893070
Start Date
July 15 2021
End Date
July 4 2022
Last Update
October 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
1er Centre Médical des Armées
Paris, France, 75012